Enter the first few characters of Company and click 'Go'
Nine Month Financial Results of Beryl Drugs Ltd.(Figures in Rs crores)
|
|
Dec 31, 2023 |
Dec 31, 2022 |
Dec 31, 2021 |
Dec 31, 2020 |
Dec 31, 2019 |
Other Income |
0.16 |
0.29 |
0.11 |
0.58 |
0 |
Raw Material |
10.43 |
10.89 |
5.92 |
4.98 |
5 |
Power And Fuel |
0 |
0 |
0 |
0 |
0 |
Employee Expenses |
1.44 |
1.25 |
1.02 |
0.85 |
0.71 |
Excise |
|
|
|
|
|
Admin And Selling Expenses |
0 |
0 |
0 |
0 |
0 |
Research And Devlopment Expenses |
0 |
0 |
0 |
0 |
0 |
Expenses Capitalised |
0 |
0 |
0 |
0 |
0 |
Other Expenses |
9.71 |
6.58 |
3.35 |
2.49 |
3.25 |
Provisions Made |
0 |
0 |
0 |
0 |
0 |
Interest |
0.33 |
0.36 |
0.34 |
0.32 |
0.18 |
Gross Profit |
2.32 |
1.58 |
0.52 |
1.07 |
1.18 |
Depreciation |
0.89 |
0.66 |
0.82 |
1.04 |
0.41 |
Taxation |
0.32 |
0.22 |
-0.11 |
-0.09 |
0.20 |
Extra Ordinary Item |
0 |
0 |
0 |
0 |
0 |
Prior Year Adjustments |
0 |
0 |
0 |
0 |
0 |
Equity Capital |
5.07 |
5.07 |
5.07 |
5.07 |
5.07 |
Equity Dividend Rate |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non-Prom. Shares (in lacs) |
0 |
0 |
0 |
0 |
0 |
Agg.Of Non PromotoHolding (%) |
0 |
0 |
0 |
0 |
0 |
EPS (in Rs.) |
2.20 |
1.39 |
-0.36 |
0.24 |
1.12 |
|
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article